Instalab
logoInstalab

Pistachio (Pis v 1) IgE

Blood Test
Pinpoint whether pistachio is a true allergy or just a harmless cross-reaction with cashew.
4.8 (2,260 reviews)
Tested by Diagnostic Solutions Lab
Physician-reviewed results
Results in under 1 week
How it works
Order from Instalab
No prescription or your own doctor's order needed
Get blood drawn
At home
Get results
Explained with clear next steps, no medical jargon

Should you take a Pistachio (Pis v 1) IgE test?

This test is most useful if any of these apply to you.

Already Allergic to Cashew
Pistachio and cashew cross-react heavily. This test helps clarify whether you also need to avoid pistachio.
Reacted After Eating Pistachio
If you have had hives, swelling, or worse after pistachio, this pinpoints the storage protein most tied to real reactions.
Managing a Child With Multi-Nut Sensitization
When a child's nut panel lights up across many nuts, component testing helps separate true allergy from harmless cross-reactivity.
Positive Panel but No Symptoms
A surprise positive on a broader nut panel often reflects cross-reaction, not allergy. This test helps tell whether pistachio is a real concern.

About Pistachio (Pis v 1) IgE

If you have ever reacted to pistachios, tested positive on a broad nut allergy panel, or had a confirmed cashew allergy and wondered whether pistachios are also off-limits, this test gets you closer to a real answer. It measures antibodies aimed at a specific pistachio protein that is closely tied to true clinical reactions, not just sensitization that may never cause symptoms.

Pistachio allergy often travels with cashew allergy, and standard nut panels frequently muddy the picture by flagging cross-reactions that are biologically real but clinically harmless. This test isolates the storage protein most associated with actual reactions, helping separate people who need strict avoidance from those whose positive nut tests may be misleading.

What This Test Actually Measures

Pis v 1 (pistachio storage protein 1) is a 2S albumin, one of the officially recognized pistachio allergens and a major driver of pistachio allergy. The test detects IgE (immunoglobulin E) antibodies in your blood that specifically target this protein. IgE is the antibody class responsible for immediate allergic reactions, including hives, swelling, and anaphylaxis.

Storage proteins like Pis v 1 are structurally tough. They resist heat and digestion, which is why they tend to trigger systemic reactions rather than just mouth tingling. This is in contrast to pollen-related nut allergens, which often cause milder, more localized symptoms. Detecting IgE against Pis v 1 specifically suggests your immune system has built a response to a protein with real reaction potential.

The Cashew-Pistachio Connection

Pis v 1 shares a substantial portion of its protein sequence with Ana o 3, the equivalent storage protein in cashew. This molecular overlap explains why cashew and pistachio allergies cluster together so tightly. Pediatric studies have shown that cashew-specific and pistachio-specific IgE levels correlate very closely, often near-perfectly.

Among children with confirmed cashew allergy, roughly two-thirds to three-quarters are also clinically allergic to pistachio in challenge-based studies. But broader sensitization (a positive IgE test without confirmed reaction) overshoots true allergy: many children show IgE binding to pistachio yet tolerate it on a supervised challenge. That gap is the entire point of testing Pis v 1: sensitization is not the same as allergy, and standard whole-nut tests cannot reliably tell them apart.

How Pis v 1 IgE Predicts Real Reactions

A pediatric study using a multiplex test found that Pis v 1 IgE was among the best predictors of clinical reactivity to pistachio and cashew, especially when combined with cashew Ana o 3 IgE. Most children with confirmed clinical reactions to pistachio or cashew had detectable Pis v 1 IgE.

Higher antibody levels carry more weight. Very high Pis v 1 IgE values reached very high specificity and positive predictive value for clinical reactivity, meaning essentially everyone at those levels truly reacted. Moderate elevations gave the best overall accuracy for pistachio. Low positive values still indicate sensitization but do not by themselves prove allergy.

Why a Standard Nut Panel Often Falls Short

A typical nut panel measures IgE against whole-pistachio extract, which contains a mix of proteins, some clinically meaningful and some not. This pulls in cross-reactions with pollens and other nuts that may never cause real symptoms. The result: many positive panel results in people who eat pistachios with no problem, and occasional false reassurance in people with low whole-extract values who actually do react.

In one analysis, many children who failed a pistachio oral food challenge had whole pistachio IgE below standard positive cutoffs. Whole-extract IgE has high specificity at very high values but poor sensitivity at standard cutoffs. Component testing for Pis v 1 helps fill that gap by zeroing in on a protein with stronger clinical meaning.

Anaphylaxis Risk

Tree nuts, including pistachio, are among the most common triggers of severe food-allergic reactions in children, and the storage proteins are the ones most often implicated. Pis v 1 sits squarely in this high-risk family alongside cashew Ana o 3, walnut Jug r 1, and hazelnut Cor a 14.

This is why your number matters: a confirmed Pis v 1 IgE positive result, particularly at higher levels, points to risk of systemic reactions, not just minor symptoms. It is also why simple sensitization without testing for specific components can leave you unsure whether to carry epinephrine, avoid all tree nuts, or take a calculated risk on cashew and pistachio.

Polysensitization Across Nuts

Pis v 1 belongs to a broader family of seed storage proteins that includes major allergens in cashew, walnut, hazelnut, peanut, and others. Children with positive Pis v 1 IgE often show co-sensitization across several of these nuts. This pattern, called storage-protein-driven polysensitization, tends to carry higher risk than pollen-related nut sensitization.

In peanut-allergic Canadian children studied for tree nut cross-reactivity, the storage protein family (2S albumins, 7S vicilins, 11S legumins) drove most of the IgE binding to pistachio. This suggests that if you carry a peanut or cashew allergy, looking specifically at pistachio storage proteins helps clarify whether pistachio should be in or out of your diet.

Tracking Your Trend

A single Pis v 1 IgE reading is a snapshot. Allergy biology can shift over time, particularly in children, where some food allergies resolve and others persist. Tree nut allergies tend to be more persistent than milk or egg allergy, but levels can still change, and tracking yours over time tells you whether your immune system is calming down or holding steady.

A practical approach: get a baseline now, retest in 6 to 12 months if you are considering reintroducing pistachio or cashew under medical supervision, and recheck at least every 1 to 2 years if you are managing a known nut allergy. Falling values may support a supervised oral food challenge. Rising or stable high values reinforce strict avoidance and the need to carry emergency medication.

When Results Can Be Misleading

A few factors can complicate interpretation of a single Pis v 1 IgE result:

  • Sensitization without clinical allergy: detectable Pis v 1 IgE means your immune system recognizes the protein, but does not guarantee you will react when you eat pistachio. A meaningful share of cashew-sensitized children in studies tolerated pistachio despite positive tests.
  • Low values do not fully exclude allergy: in pistachio-challenge studies, some children with clinically confirmed pistachio allergy had IgE values well below standard positive cutoffs. A low result lowers but does not eliminate risk.
  • Total IgE distortion: very low or very high total IgE can shift the interpretation of any single specific-IgE result. Multiplex testing studies found that filtering out extremely low total IgE samples improved prediction accuracy.
  • Cross-reactivity confusion: because Pis v 1 shares so much sequence with cashew Ana o 3, a positive Pis v 1 result in someone with cashew allergy may reflect cross-binding rather than primary pistachio sensitization. Interpretation should consider both proteins together.
  • Anti-IgE therapy interference: if you are on omalizumab, standard specific-IgE assays may not accurately reflect your true free IgE level, since the drug binds circulating IgE rather than reducing its production.

What to Do With an Unexpected Result

If your Pis v 1 IgE comes back positive but you have never reacted to pistachio, do not assume you can eat it freely, and do not assume you must avoid it forever. The next step is usually a conversation with an allergist about pairing your result with cashew Ana o 3 IgE, skin prick testing, and possibly a supervised oral food challenge, which remains the gold standard for confirming or excluding clinical allergy.

If your level is high, especially in combination with a confirmed reaction history, the practical action is strict avoidance of both pistachio and cashew, plus carrying epinephrine. A low-level positive in someone without symptoms is a candidate for further workup rather than immediate dietary restriction. If you carry a known cashew allergy, getting both Ana o 3 and Pis v 1 measured gives you a clearer cross-reactivity map than either alone.

What Moves This Biomarker

Evidence-backed interventions that affect your Pistachio (Pis v 1) IgE level

Decrease
Cashew oral immunotherapy
Gradually eating tiny then larger doses of cashew under medical supervision desensitized most patients to cashew and also produced cross-desensitization to pistachio. In the NUT CRACKER study of cashew-allergic patients, all pistachio co-allergic participants were cross-desensitized to pistachio after cashew OIT, which is biologically consistent with shifts in storage-protein IgE responses, though Pis v 1 IgE itself was not the primary outcome reported.
MedicationModerate Evidence
Increase
Omalizumab (anti-IgE biologic)
This injectable medication binds free IgE in the blood and reduces the functional impact of food-specific IgE, including for tree nuts. In a randomized trial, 16 weeks of treatment raised the reaction threshold for peanut and other common food allergens compared with placebo. Clinical reactivity improves, but the measured Pis v 1 IgE level on a standard blood test may not fall, and in some assays can appear paradoxically higher because the drug binds rather than removes circulating IgE.
MedicationModerate Evidence
Decrease
Dupilumab
This biologic, mainly used for atopic dermatitis and asthma, reduces total and food-specific IgE levels over months of treatment. In a phase II trial in peanut-allergic children, dupilumab lowered peanut-specific IgE by about 49% but only 8.3% of treated children met the desensitization endpoint on oral food challenge. Marked as neutral because the number falls without a confirmed reduction in real-world allergic reactivity to nuts.
MedicationModerate Evidence

Frequently Asked Questions

References

12 studies
  1. Costa J, Silva I, Vicente AA, Oliveira M, Mafra ICritical Reviews in Food Science and Nutrition2019
  2. Perry T, JM, Rudengren M, Ahlstedt, Bock SA, Sampson HAJournal of Allergy and Clinical Immunology2008